Dose-modified abiraterone acetate (AA) in men with metastatic castration-resistant prostate cancer (mCRPC): The Princess Margaret Cancer Centre (PM) experience.
Raya Leibowitz-Amit
No relevant relationships to disclose
Eshetu G. Atenafu
No relevant relationships to disclose
Jo-An Seah
No relevant relationships to disclose
Arnoud J. Templeton
Honoraria - Janssen-Cilag
Francisco Emilio Vera-Badillo
No relevant relationships to disclose
Henry L. Solow
No relevant relationships to disclose
Jennifer J. Knox
No relevant relationships to disclose
Srikala S. Sridhar
Consultant or Advisory Role - Janssen-Ortho
Honoraria - Janssen-Ortho; Pfizer; Sanofi
Research Funding - Janssen-Ortho; Pfizer; Sanofi
Ian Tannock
No relevant relationships to disclose
Anthony Michael Joshua
Research Funding - Janssen-Ortho